Serena Williams has again modeled a swimsuit following the backlash over her use of the weight-loss drug, Ro. The tennis star was photographed via Instagram wearing an olive green one-piece swimsuit while posing outdoors. She wrapped up the summer look with a fuzzy pink dress and a pair of Ugg slippers while posing casually in … Read more
In the last two years Eli Lilly (NYSE: LLY ) It has established itself as a leader in the weight loss market. This is thanks to the company’s Terzapatide, a compound sold under the name Zipbound as an anti-obesity drug (and Monjaro in the treatment of diabetes) that became the world’s best-selling drug in 2025. … Read more
In the last two years Eli Lilly (LLY +0.80%) It has established itself as a leader in the weight loss market. This is thanks to the company’s Terzapatide, a compound sold under the name Zipbound as an anti-obesity drug (and Monjaro in the treatment of diabetes) that became the world’s best-selling drug in 2025. ZipBound … Read more
A 30-year-old company employee was filled with self-loathing every time she saw a thin woman on a tic-tac train and realized “how fat I am.” The Hokkaido resident visited a cosmetic clinic and had liposuction done on almost her entire body. She still felt that these procedures were too slow to produce the desired effect … Read more
5 minutes of reading Tony Alvarado, 45, is a mathematics professor at Rice University from Houston, Texas, and has a history of heart problems. A combination of too little exercise, stress eating, and drinking contributed to weight gain that threatened his livelihood. Here’s how he put his act together through a comprehensive diet plan that … Read more
In the early 1970s, psychologists at Northwestern University conducted an experiment that, on the surface, looks like a child’s imagination. Researchers gathered 45 college women and asked them to drink a shake or two. Then they placed three pints of ice cream in front of each woman and asked her to eat each one. Afterwards, … Read more
Lallemand Bio-ingredients has launched Re-Vaya, an ingredient that addresses the growing demand for metabolic health, supporting balance through a health optimization approach. The science-backed ingredient launches at a time when demand for the usual weight loss narrative is changing, reshaping the metabolic health landscape beyond single-target weight management. Nutrition Insights Lallimand Bio Ingredients Scientific Affairs … Read more
Listen to the article 4 minutes This audio is automatically generated. Please let us know if you have feedback. After losing significant ground to rival Eli Lilly in the GLP-1 space over the past two years, Novo Nordisk is defending the field it now dominates — oral therapies. But as Lilly prepares to launch an … Read more
Researchers at the University of Virginia School of Medicine have received $3.4 million from the National Institutes of Health to increase the availability of weight management programs that offer helpful personalized feedback. Rebecca Krukowski, Ph.D., and her colleagues aim to support people in weight management programs that track or “self-monitor” their diet, exercise and weight. … Read more
As the use of injectable GLP-1 drugs continues to increase, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that, on average, ceasing semaglutide and terzapatide does not lead to significant weight regain in clinical practice, as many patients later resume … Read more